Strategy & Corporate Planning

Biotechnology Business Fundamentals: Biopharma Pipeline, Licensing and Partnering – Riyadh, 19–23 Sep 2027

Biotechnology Business Fundamentals: Biopharma Pipeline, Licensing and Partnering runs in Riyadh from Sunday 19 September to Thursday 23 September 2027 (1 Week). The fee is 20,000 SAR per participant. The same programme is also scheduled in 7 other cities.

Register for this programme Ask a question

Dates
Length
1 Week
Fee per participant
20,000 SAR
Format
In person, Riyadh
Venue
KAFD district five-star
Status
Open for registration
Week
37 of 2027
Reference
576_17588

This session

19–23 Sep 2027

This Biotechnology Business Fundamentals: Biopharma Pipeline, Licensing and Partnering session in Riyadh runs from Sunday 19 September to Thursday 23 September 2027 (week 37, Q3 2027). It is the only date in Riyadh in 2027, at a fee of 20,000 SAR. Registration is open for this date. It is held in person at KAFD district five-star.

How do I book this date?

Register online to request your place, or send us a question about this date first.

Reference for this date: 576_17588. Quote it when you contact us.

Before you book, read our cancellation policy.

Let’s talk about your next step.

Questions about this date

When does Biotechnology Business Fundamentals: Biopharma Pipeline, Licensing and Partnering in Riyadh start and finish?

It starts on Sunday 19 September and finishes on Thursday 23 September 2027: 1 Week.

How much does Biotechnology Business Fundamentals: Biopharma Pipeline, Licensing and Partnering in Riyadh cost?

The fee for this date is 20,000 SAR per participant. Please read our cancellation policy before you book.

Is this date held in person or online?

It is held in person in Riyadh, at KAFD district five-star.

Where else does Biotechnology Business Fundamentals: Biopharma Pipeline, Licensing and Partnering run?

It is also scheduled in 7 other cities: Amsterdam, Barcelona, Dammam, Dubai, Jeddah, London and Paris.

What does this programme cover?

Biotechnology business decisions are increasingly made by managers, investors and officials who never trained as scientists. Without a working grasp of how biologic medicines are discovered, developed, protected, financed and made, they misread pipeline risk, overpay for early assets, sign licences with the wrong milestones or back manufacturing plans that never fill. This Core Concept course gives non-scientist professionals the science vocabulary, pipeline economics, deal structures and ecosystem logic of the biopharma sector. Participants finish with a Biotech Asset Evaluation and Partnering Strategy for a case asset.

The programme outline covers:

  • Introduction
  • Course Objectives
  • Target Audience
  • Course Outline
  • Day 1: Biotechnology Science Essentials for Non-Scientists
  • Day 2: Therapeutic Modalities and the Development Pipeline
  • Day 3: Regulation, Intellectual Property and Asset Valuation
  • Day 4: Funding, Partnering, Manufacturing and Market Access
  • Day 5: Biotech Ecosystem Strategy and Partnering Case
  • Skills You Will Gain
  • Why Attend This Course
  • Conclusion
Read the full outline on the programme page ↗

Where else does this programme run?

Also scheduled in 7 other cities.

More ways to train